Semaglutide (Ozempic®) Use in Denmark 2018 Through 2023 ‒ User Trends and off-Label Prescribing for Weight Loss

Aurélie Mailhac,1 Lars Pedersen,1 Anton Pottegård,2 Jens Søndergaard,3 Torben Mogensen,4 Henrik Toft Sørensen,1 Reimar W Thomsen1 1Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark; 2Clinical Pharmacology, Pharmacy, and Environmental Medicine, Dep...

Full description

Bibliographic Details

Published in:	Clinical Epidemiology
Main Authors:	Mailhac A, Pedersen L, Pottegård A, Søndergaard J, Mogensen T, Sørensen HT, Thomsen RW
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-04-01
Subjects:	drug utilization epidemiology anti-obesity drugs glucose-lowering drugs obesity type 2 diabetes
Online Access:	https://www.dovepress.com/semaglutide-ozempic-use-in-denmark-2018-through-2023--user-trends-and--peer-reviewed-fulltext-article-CLEP